Bio Rad Laboratories Inc
NYSE:BIO
Bio Rad Laboratories Inc
NYSE:BIO
Price:
294.01 USD
3%
Market Closed
Updated:
May 15, 2024
Bio Rad Laboratories Inc
Operating Expenses
|
Bio Rad Laboratories Inc
Operating Expenses Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bio Rad Laboratories Inc
NYSE:BIO
|
Operating Expenses
-$1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Expenses
-$9.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-10%
|
|
|
Danaher Corp
NYSE:DHR
|
Operating Expenses
-$16.1B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-10%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Expenses
-$1.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Expenses
-$2.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Expenses
-$3.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-14%
|
See Also
What is Bio Rad Laboratories Inc's Operating Expenses?
Operating Expenses
-1B
USD
-1B
USD
Based on the financial report for Mar 31, 2024, Bio Rad Laboratories Inc's Operating Expenses amounts to -1B USD.
What is Bio Rad Laboratories Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
0%
0%
Over the last year, the Operating Expenses growth was 5%. The average annual Operating Expenses growth rates for Bio Rad Laboratories Inc have been -1% over the past three years .
You don't have any saved screeners yet
